
Cardio-oncology lives at the juntion between two fast-moving fields. Cancer treatment keeps improving, patients live longer, and more of those patients carry cardiovascular risk that has to be managed alongside their oncology care. That much is not…

I recently attended ESC Cardio-Oncology 2026 in Vienna. Alongside other major international gatherings like Global Cardio-Oncology Summit, the ESC Cardio-Oncology Conference remains a vital forum for experts at the intersection of cardiology and cancer care. This trip wasn’t just…

Quick answer Structured exercise during and after cancer treatment is safe for most patients, protects the heart against the long-term cardiovascular consequences of cancer therapy, and in stage III or high-risk stage II colon cancer now has…

A new state-of-the-art review on risk prediction in cardio-oncology, and an invitation to help build the tools this field still needs.

The moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…

Dr Jonathan Sen explains why a full year of dedicated cardio-oncology fellowship, with integrated imaging and research at UHN Toronto, shapes better cardiac care for cancer patients in Brisbane.